MicroRNAs, which regulate mRNAs, operate through a variety of signaling pathways to participate in the development of colorectal cancer (CRC). In this study, we found that microRNA (miR)-143-3p expression was significantly lower in both CRC and liver metastatic CRC tissues from liver compared with normal colonic tissues. Functional assays showed that miR-143-3p inhibited CRC cell invasion and migration in vitro.
| INTRODUC TI ON
Colorectal cancer (CRC) is the third most common cancer in both men and women. 1 Although early surgery is recommended, this treatment is limited by the fact that 25% of CRC patients have clinically detectable liver metastases at initial diagnosis. 2 Even after resection of liver metastases, more than 50% of patients cannot be cured due to recurrence and other distant metastases. 3, 4 Many molecular targeted therapies have shown remarkable clinical success in the treatment of many cancer types including CRC; however, common adverse effects include rash, diarrhea, hypertension, hypothyroidism, proteinuria, depigmentation, and hepatotoxicity. 5 It is therefore essential to explore now molecular targets for the treatment of CRC.
MicroRNAs (miRNAs) are short endogenous noncoding RNAs that repress gene expression in eukaryotic organisms. Many studies have shown a correlation between dysregulated miRNAs and the aberrant regulation of signaling pathways involved in CRC initiation and progression. The downregulation of miR-143 and miR-145 in CRC relative to normal colon epithelial cells was first reported by Michael et al. 6 Many other studies have reported the tumor suppressive or oncogenic functions of miRNAs in CRC. 7, 8 Therefore, miRNAs could also represent novel therapeutic targets for gene therapy in the treatment of CRC.
Based on previously identified miRNAs that were decreased in CRC compared with normal colonic tissues (see NCBI GBO platform,
No. GSE53339), miR-143-3p was selected for further study. Here, we
show that exogenous miRNA-143-3p inhibits CRC invasion and metastasis. Furthermore, we reveal the following target genes of miR-143-3p: integrin alpha 6 (ITGA6) and Arf GTPase activating protein (ArfGAP) with SH3 domain, ankyrin repeat, and PH domain 3 (ASAP3), and their reciprocal relationship was confirmed in CRC cells and tissues. Our findings suggest that miR-143-3p, ITGA6, and ASAP3 could be valuable targets for the management of CRC progression.
| MATERIAL S AND ME THODS

| Patients and tissue specimens
Clinical specimens for the miRNA microarray were obtained from 6 patients who had been diagnosed as having CRC with liver metastasis at the First Affiliated Hospital of Soochow University (Suzhou, China). Liver metastatic CRC tissues were obtained from these patients, and informed written consent was provided. All of the patients underwent surgical resection between March 2014 and December 2014, and none had received preoperative radiotherapy, chemotherapy, or other treatments. Specimen sampling included CRC tissue and corresponding normal colorectal tissue from an area more than 5 cm from the lesion. Specimens were obtained aseptically during surgery and were immediately placed in liquid nitrogen.
| Total RNA extraction and quantitative RT-PCR
Total RNA was harvested from CRC surgical specimens using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and reverse transcribed according to the manufacturer's recommendations. The cDNA acted as the template for the amplification of RNA, and real-time PCR was used for microRNA (miR)-143-3p amplification and TaqMan miRNA assays (Takara Shuzo, Kyoto, Japan) were used for quantification following amplification. The small nuclear RNA U6 was used as a normalization control. The RT reaction comprised of 16°C for 30 minutes, 42°C for 42 minutes, and 85°C for 5 minutes. The following program was used for quantitative PCR: 95°C for 10 minutes, 40 cycles of 95°C for 15 seconds, and then 60°C for 60 seconds. Relative expression changes were calculated using the 2 −ΔΔC T method.
| MicroRNA array analysis
Total RNA was extracted from 3 sets of paired liver metastases from CRC tumors, primary CRC tumors, and adjacent normal tissues. RNA was quantified using a NanoDrop 1000 spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA), and the samples were labeled using the miRCURY Hy3/Hy5 Power labeling kit and hybridized on the miRCURY LNA Array (version 6.0) (Exiqon, Vedbaek, Denmark).
Following washing, the slides were scanned using the Axon GenePix 4000B microarray scanner (Axon Instruments, Foster City, CA, USA).
Scanned images were then imported into GenePix Pro 6.0 software (Axon Instruments) for grid alignment and data extraction. Expressed data were normalized using median normalization. Finally, hierarchical clustering was carried out to determine distinguishable miRNA expression profiles among the samples.
| Oligonucleotide synthesis and transfection
LNA/DNA hybrid oligonucleotides (miR mimic sequence, UGAGAUGAAGCACUGUAGCUC) and control oligonucleotides and ASAP3 RNA interference (synthesized by Guangzhou RiboBio).
The siRNA transfection was carried out following the same procedures used for microRNA at a final concentration of 30 nM. A microplate reader was used to determine the OD value at 560 nm. 
| Cell proliferation assay
| Migration and invasion assay
| Wound healing assay
Cells were cultured on 6-well plates to form a single cell layer, and a straight wound line was made in the middle of the cell layer. After culturing for 24 or 48 hours, cells that migrated into the wound line were observed. Images of the cells along the wound line were then taken by phase-contrast microscopy.
| Western blot analysis
Cells were collected and lysed in TNES buffer. Equal aliquots of proteins were electrophoresed on SDS-polyacrylamide gels and electro- 
| Tissue microarray construction
To construct the tissue microarray, CRC paraffin-embedded tissue samples from 200 cases and normal colorectal tissue samples from 50 cases obtained at the First Affiliated Hospital of Soochow University were used. In the corresponding paraffin block, 1.5-mm cores were punched out (1 core per case). These cores, each 5-7 mm high, were then embedded in the donor block using a manually operated tissue microarray device.
| Immunohistochemical analysis
The sections of paraffin-embedded tissue were incubated with 0.3% hydrogen peroxide for 10 minutes to block endogenous peroxidase activity. The slides were then subjected to antigen retrieval as follows. After boiling in 10 mM citrate buffer for 10 minutes in a microwave oven, the tissue sections were incubated with 10% 
| Statistical analysis
All data are presented as the mean ± SD. Statistical analyses were carried out using SPSS, version 20 (SPSS, Chicago, IL, USA).
Independent sample t test was used to compare the significance of the differences between 2 groups. P < .05 was considered statistically significant after 2-tailed t tests and significant differences are denoted by an asterisk in the figures. *P < .05, **P < .01, ***P < .001.
| RE SULTS
| Differential expression of miR-143-3p between primary CRC and liver metastatic CRC
In our previous research, we used a miRNA microarray (Exiqon version 18.0) to detect miRNAs that were differentially expressed between 6 CRC tissues and normal colonic tissues and identified miR-143-3p as one of the most significantly decreased in CRC tissues (34.8-fold) compared with normal colonic tissues (Query No. GSE53339). In this study, we used a miRNA microarray to detect the differential expression of miRNAs in 3 primary CRC tissues and liver metastatic CRC tissues (high, moderate, and poorly differentiated adenocarcinomas), and compared these with 3 normal colonic tissues. Hierarchical cluster analysis generated a dendrogram with 2 major branches both in columns (primary CRC vs normal, liver metastatic CRC vs normal) and in rows (upregulated vs downregulated genes). The criteria used to define significantly altered miRNAs were: (i) mean fold change >3 or <0.3333; and (ii) P-value <0.05. Statistical analysis revealed only 1 miRNA that was significantly decreased in primary CRC tissue compared with normal colonic tissue, but more than 10 miRNAs were decreased in expression in liver metastases compared with normal colonic tissue, of which miR-143-3p showed the greatest decrease (59-fold; Figure 1A and Table 1 ).
Reverse transcription-PCR was used to detect the expression level of miR-143-3p in 12 primary CRC tissues and 8 liver metastatic CRC tissues, compared with normal colonic tissue samples. The results showed that the proportion of primary CRC cases in which miR-143-3p was decreased by more than 5-fold was 25% (3/12), whereas this proportion in liver metastatic CRC cases was 50% (4/8) ( Figure 1B ). This significant reduction in miR-143-3p expression in liver metastatic CRC suggests some underlying mechanism involving this miRNA.
| MicroRNA-143-3p inhibits the invasion and migration of CRC cells in vitro
We transiently transfected synthesized miR-143-3p mimics into LoVo cells (which have low endogenous miR-143-3p expression) and verified that miR-143-3p expression was significantly increased in the transfected cells ( Figure S1 ). To explore the effect of miR-143-3p
on the biological behavior of CRC, we used an MTT assay to determine the proliferation ability of LoVo cells 24, 48, 72, and 96 hours after transfection with miR-143-3p-mimics, but no significant differences between the miR-143-3p mimic-treated group and the control group were detected (Figure 2A) . We then used a Transwell assay to detect the migration and invasion ability of LoVo cells. As shown in Figure 2B , both the migration and invasion ability of LoVo cells significantly decreased 24 hours after transfection with miR-143-3p mimics compared with the control groups. These results indicated that miR-143-3p has no effect on the proliferation of LoVo cells, but has a regulatory role in the metastasis of CRC.
| ITGA6 and ASAP3 are targets of miR-143-3p
Bioinformatic searches using the online resources TargetScan, MIRDB, DIANA-MICROT, and MICRORNA.ORG, identified 20 predicted targets of miR-143-3p that overlapped between these 4 bioinformatics websites. Then, based on the analysis of function using data from the miR-Ontology database, we identified 4 target genes of miR-143-3p: ASAP3, MSI2, CRELD1, and ITGA6
( Figure 3A) . The correlation between these target genes and CRC has not previously been reported.
To determine whether miR-143-3p was negatively correlated with the expression of candidate target genes, we used western blot analysis to detect the expression of each candidate target gene in LoVo cells transfected with miR-143-3p mimics. The results showed that only ITGA6 and ASAP3 were significantly reduced in expression among these predicted target genes ( Figure 3B ). Realtime PCR was then carried out and revealed that the increase in miR-143-3p concentration following the transfection of miR-143-3p mimics resulted in a gradual decrease in the mRNA expression of the ITGA6 and ASAP3 genes. When the concentration of transfected miR-143-3p mimics was 100 nmol, the expression level of ITGA6 mRNA was decreased by approximately 4.5-fold, and the expression level of ASAP3 mRNA was decreased by more than 5 times that in the control groups (P < .01) (Figure 3C,D) .
These results suggested that ITGA6 and ASAP3 are likely target genes of miR-143-3p. A wound healing assay showed that the migration distance of LoVo cells was significantly shorter in the two siRNA interference groups compared with the control groups ( Figure 4C ). The same results were confirmed in other cell lines (SW480 and HCT116). Then we applied an MTT assay to determine the proliferative ability of CRC cells following transfection with ITGA6 or ASAP3 siRNA.
However, it was found that both ITGA6 and ASAP3 siRNA had no effect on the proliferation of CRC cell lines (LoVo, SW480, and HCT116; Figure 4D ). Taken together, these results suggest that the overexpression of both ITGA6 and ASAP3 in CRC cells could play a key role in the progression of CRC and especially in the metastasis of this cancer.
| ITGA6 and ASAP3 are highly expressed in CRC tissues
To investigate the expression of ITGA6 and ASAP3 in CRC,
we prepared a tissue microarray with 200 CRC surgical specimens and 50 normal tissues ( Figures 5 and S3 ) and the ITGA6 and ASAP3 protein expression levels are shown in Table 2 . respectively, revealing a significant difference (P < .05, Table 2 ).
Furthermore, the positive detection rates of ASAP3 in tumor tissues and normal tissues were 39.5% (79/200) and 16% (8/50), respectively; again these differences were statistically significant (P < .05, Table 2 ).
| Relationship between clinicopathological features and ITGA6/ASAP3 protein expression
The (Table 3 ).
| D ISCUSS I ON
The downregulation of miR-143-3p has been reported in endometrial cancer, 9 non-small cell lung cancer, 10 bladder cancer, 13 AKT serine/threonine kinase 2 (AKT2), 14 mitogen-activated protein kinase 7 (MAPK7), 15 and DNA methyltransferase 3A (DNMT3A). 16 In this study, we used bioinformatics software to As a transmembrane glycoprotein-adhering receptor, ITGA6
5),
mediates cell-matrix and cell-cell adhesion. 17, 18 
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